In particular, cell lines made resistant to doxorubicin by continous drug exposure were compared with doxorubicin-naïve cells to decipher the role of Akt-mTOR-S6K signaling in breast cancer chemoresistance. This evidence concerns the gene AKT1 and breast carcinoma.